Covid-19 Drugs

COVID-19 Drugs: Canada’s New Antiviral BOLD-100 Beats Remdesivir In Vitro Studies Involving SARS-CoV-2 Infected Vero E6 Cells

Source: COVID-19 Drugs Aug 18, 2020 4 years ago

COVID-19 Drugs: Canadian based Bold Therapeutics, a clinical-stage biopharmaceutical company, have recently generated more key data supporting the rapid clinical development of a new therapeutic drug called BOLD-100 as an antiviral against the SARS-CoV-2 coronavirus. The therapeutic drug BOLD-100 is a first-in-class ruthenium-based small molecule drug which selectively inhibits stress-ind...

COVID-19 Drugs: Yale Study Shows That Janus Kinase-Inhibitors And Type I Interferon Reduces Mortality Risk in COVID-19 Patients

Source: COVID-19 Drugs Aug 14, 2020 4 years ago

COVID-19 Drugs: With global death rates now reaching more than 754,000 (168,000 just in America alone) and the official infected cases at more than 22 million, medical researchers are desperate to find drugs and treatment protocols that can at help reduce mortality rates. To date there is no real effective drugs that can really treat COVID-19 effectively (remdesivir ‘s efficacy is now being ...

COVID-19 Treatments: University of California Introduces Aeronabs-An Inhaler That Releases Highly Potent Antiviral Nanobodies Against The SARS-COV-2

Source: COVID-19 Treatments Aug 13, 2020 4 years ago

COVID-19 Treatments: University Of California-San Francisco scientists have developed a novel approach to halting the spread of SARS-CoV-2 involving an aerosol formulation of nanobodies that are basically antiviral molecules that inhibit the virus. The research and development lead by graduate student Michael Schoof, along with a team of researchers engineered a completely synthetic...

NEW THERAPEUTIC TEAS

Source: COVID-19 Herbs And Therapeutic Teas Aug 09, 2020 4 years ago

Therapeutic Teas is a range of herbal teas specially created for the COVID-19 crisis after 6 months of intense research and is still evolving daily based on emerging daily COVID-19 research.We do not make any claims about what the teas are good for or what it can do and achieve in terms of health benefits but rather we let readers do their own due diligence based on the accompanying published rese...

COVID-19 Warnings: Usage Of Antiviral Of Lopinavir-Ritonavir To Treat COVID-19 Linked To Numerous Drug Interactions And Even Deaths

Source: COVID-19 Warnings Aug 08, 2020 4 years ago

COVID-19 Warnings: Researchers from COVID-19 Infectious Diseases and Microbiology Unit, Hospital Universitario Virgen de Valme- Spain have discovered that the usage of the antivirals Lopinavir-Ritonavir (LPV-r ) can lead to numerous drug interactions that can be detrimental to health conditions and even cause death in certain situations as a result of these interactions. Despite numerous st...

COVID-19 Treatments: With No Effective Antivirals, Doubts About Antibody Therapies And Vaccines, Hope Now Turned To Intravenous Immunoglobulins

Source: COVID-19 Treatments Aug 08, 2020 4 years ago

COVID-19 Treatments: With no proper effective antivirals against the SARS-CoV-2 to date and mounting skepticism about antibody therapies and vaccines due to conflicting research studies as to whether real long time immunity protection against the SARS-CoV-2 can be truly achieved and with issues arising from all so called discovered repurposed drugs to deal with anti-inflammatory issues and cytokin...

COVID-19 Research: More Studies Showing High Dose Vitamin C Linked To Faster Recovery In COVID-19 Patients With Severe Conditions

Source: COVID-19 Research Aug 04, 2020 4 years ago

COVID-19 Research: Numerous new studies are emerging that shows high dose Vitamin C could be useful in treating COVID-19 patients after initial skepticisms by certain medical doctors and researchers linked to the big pharmaceutical companies who were most probably paying these unethical medical professionals. In the early stages of the COVID-19 pandemic, results of an analysis published in the ...

BREAKING NEWS! COVID-19 Drugs: Texas Researchers Identify Extremely Potent SARS-Cov-2 Inhibitors

Source: COVID-19 Drugs Aug 01, 2020 4 years ago

COVID-19 Drugs: Researchers from Texas A & M University, University of Texas-Galveston and the University Of North Texas have identified a series of potent enzyme inhibitors that are able to suppress SARS-CoV-2 replication by interfering with one of the primary viral proteases. The researchers urge rapid clinical and preclinical testing of their most potent compounds to meet the need ...

BREAKING! COVID-19 Drugs: Harvard Study Shows That Tetracyclines Can Treat COVID-19 Acute Respiratory Distress Syndrome (ARDS) And Also Act As A Prophylaxis

Source: COVID-19 Drugs Jul 30, 2020 4 years ago

COVID-19 Drugs: Most people have a fallacy that tetracyclines only work as antibiotics without knowing that these drugs also possess immunomodulatory and anti-inflammatory properties as well. The SARS-Cov-2 coronavirus seems to attack the human airway epithelium primarily. In severely affected patients, the illness progresses to hypoxemic respiratory failure and acute respiratory distress...

COVID-19 Drugs: Researchers From Boston Children's Hospital Initiate Randomized Clinical Trial Of Pulmozyme To Treat Severe COVID-19 Patients

Source: COVID-19 Drugs Jul 29, 2020 4 years ago

COVID-19 Drugs: Researchers from the Boston Children's Hospital and Brigham and Women's Hospital have launched a randomized, placebo-controlled clinical trial of dornase alfa (Pulmozyme) in patients with severe COVID-19 pneumonia and respiratory failure requiring mechanical ventilation. The protein Dornase alfa (proprietary name Pulmozyme from Genentech) is a h...

COVID-19 Drugs: Yale And AI Therapeutics Launches Multi-Institutional Clinical Trial Of LAM-002A (Apilimod) To Treat COVID-19

Source: COVID-19 Drugs Jul 28, 2020 4 years ago

COVID-19 Drugs: Researchers from Yale School of Medicine and the biopharmaceutical firm AI Therapeutics have launched a multi-institutional clinical trial of a drug for treating COVID-19. The drug known as LAM-002A (apilimod), has a proven safety record. Preliminary research has shown it can block cellular entry and trafficking of the SARS-CoV-2 virus, the cause of COVID-19. Past t...

BREAKING! COVID-19 Drugs: Study Shows That Fucoidan Extracted From Seaweed Outperforms Remdesivir In Inhibiting SARS-CoV-2 In Cell Studies

Source: COVID-19 Drugs Jul 25, 2020 4 years ago

COVID-19 Drugs: Researchers from Rensselaer Polytechnic Institute-New York, Korea Research Institute of Bioscience and Biotechnology, and Zhejiang University of Technology-China in study involving the test of antiviral effectiveness against the virus that causes COVID-19, found that an extract from edible seaweeds called fucoidan substantially outperformed remdesivir, the current standard antivira...

COVID-19 Drugs: Heron Therapeutics Starts Phase 2 Clinical Study of CINVANTI (Aprepitant) For Prevention And Treatment Of Lung Injury In COVID-19 Patients

Source: COVID-19 Drugs Jul 22, 2020 4 years ago

COVID-19 Drugs: Heron Therapeutics, Inc, a commercial-stage biotechnology company announced the initiation of the GUARDS-1 Study, a Phase 2 clinical study evaluating CINVANTI (aprepitant) injectable emulsion in early hospitalized patients with COVID-19. The research study initiation follows clearance from the U.S. FDA of Heron's Investigational New Drug application for CINVANTI for th...

COVID-19 Drugs: US FDA Approves Abivertinib for Phase 2 Safety And Efficacy Study In Hospitalized Patients With Moderate To Severe COVID-19

Source: COVID-19 Drugs Jul 22, 2020 4 years ago

COVID-19 Drugs: Biophramaceutical company Sorrento Therapeutics, Inc. has received clearance from the US FDA to initiate a Phase 2 trial of Abivertinib in patients with COVID-19 who have moderate to severe pulmonary symptoms. The drug Abivertinib is a novel small molecule tyrosine kinase inhibitor (TKI) that selectively targets both mutant forms of the epidermal growth factor receptor (EG...

MUST READ! COVID-19 Scandals: More Medical Experts Criticize Claim That Remdesivir Cuts Death Rates Or Hospitalization Stays

Source: COVID-19 Scandals Jul 22, 2020 4 years ago

COVID-19 Scandals: Remdesivir is coming under more spotlight as more doctors questions its effectiveness not only in terms of its ability to cut death rates but also on its claims to shorten hospitalization stays. https://www.bmj.com/content/370/bmj.m2839 Many subsequent studies that emerged after the criticisms seems suspicious as some look as if the researchers or institutions wer...

COVID-19 Drugs: Nitric Oxide Could Slow Progression Of COVID-19 According To Study From George Washington University

Source: COVID-19 Drugs Jul 22, 2020 4 years ago

COVID-19 Drugs: According to researchers from the George Washington University (GW), nitric oxide treatment can be pivotal in the world's fight against SARS-CoV-2, the coronavirus that causes COVID-19. A review article on its usage is published in the journal Nitric Oxide. https://www.sciencedirect.com/science/article/pii/S1089860320301701?via%3Dihub As a pharmaceutical compound,...

COVID-19 Medications: Synairgen's Inhaled Interferon Beta Treatment Decreases COVID-19 Disease Risk by 79%

Source: COVID-19 Medications Jul 20, 2020 4 years ago

COVID-19 Medications: Synairgen, a British biotech company announced positive results from a clinical trial of its wholly-owned inhaled formulation of interferon beta in COVID-19 patients. Synairgen indicated its nebulizer treatment resulted in a 79% lower risk of patients developing severe disease compared to those receiving a placebo. And the patients receiving the treatment &...

COVID-19 Drugs: India Approves Biocon’s Drug Itolizumab To Treat Cytokine Storms In COVID-19 Patients

Source: COVID-19 Drugs Jul 20, 2020 4 years ago

COVID-19 Drugs: Leading Biopharmaceuticals company Biocon has secured approval from the Drugs Controller General of India (DCGI) for its plaque psoriasis drug Itolizumab (ALZUMAb) for emergency use in Covid-19 patients. The regulatory approval is for 25mg / 5ml injection solution of the medicine to treat cytokine release syndrome (CRS) in moderate to severe acute respiratory distress synd...

COVID-19 Drugs: Dexamethasone Trial Results Finally Published, Warning That Although Beneficial, Early Use In COVID-19 Patients Can Be Harmful

Source: COVID-19 Drugs Jul 18, 2020 4 years ago

COVID-19 Drugs: Dexamethasone’s much-awaited official results from a UK trial of the steroid dexamethasone were published finally a few hours ago in the New England Journal of Medicine, confirming its life-saving benefits for COVID-19 patients on ventilators but suggesting it may cause harm if given too early. https://www.nejm.org/doi/full/10.1056/NEJMoa2021436?query=featured_home In...

COVID-19 Drugs: Israeli Researchers Discover That Cholesterol-Lowering Drug Fenofibrate (Tricor) Could Downgrade COVID-19 Severity

Source: COVID-19 Drugs Jul 16, 2020 5 years ago

COVID-19 Drugs: A research team led by Hebrew University of Jerusalem (HU)'s Professor Dr Yaakov Nahmias says that a simple and inexpensive cholesterol-lowering drug called Fenofibrate (Tricor) that is been approved and on the market for decades could help downgrade the severity of COVID-19 disease. The early research finding which looks promising has been published in the preprint section of...

COVID-19 Drugs: New Research Indicates That Heparin May Effectively Neutralize SARS-CoV-2 Coronavirus That Causes COVID-19

Source: COVID-19 Drugs Jul 16, 2020 5 years ago

COVID-19 Drugs: Heparin, a common drug, already approved by the US as an anticoagulant may also be a powerful tool in fighting COVID-19, according to research published in the journal: Antiviral Research. https://www.sciencedirect.com/science/article/abs/pii/S0166354220302874?via%3Dihub The SARS-CoV-2, the virus that causes COVID-19, uses a surface spike protein to latch onto human c...

COVID-19 Drugs: Favipiravir (Avigan) Fails To Achieve Statistical Significance in Fujifilm Trial, Effectiveness Questionable

Source: COVID-19 Drugs Jul 13, 2020 5 years ago

COVID-19 Drugs: A relatively large and detailed clinical trial performed by Japanese researchers has showed inconclusive data from Covid-19 patients treated with Fujifilm’s Avigan drug also known as favipiravir. Fujita Health University researcher Professor Dr Yohei Doi said that the drug led to improvement in patients treated early, compared to those who received delayed dose...

COVID-19 Cellular Therapy: Spanish Researchers Show That New Stem Cell Therapy Reduces Severity, Mortality And Intubation Period For ICU COVID-19 Patients

Source: COVID-19 Cellular Therapy Jul 13, 2020 5 years ago

COVID-19 Cellular Therapy. Spanish researchers announced that a cellular therapy tested on 13 intubated patients with mechanical ventilation has shown to be efficient for the clinical improvement of critical cases of COVID-19. The research which is the broadest published to date in these conditions, has been published in journal: The Lancet's EClinical Medicine, after proving that the...

COVID-19 Meds: Bill Gates Says That COVID-19 Drugs And Treatments Should Go To People Who Need Them, And Not The ‘Highest Bidders’

Source: COVID-19 Meds Jul 12, 2020 5 years ago

COVID-19 Meds: With more than 140 vaccine projects and more than 420 drug trials under way and governments in Europe and the United States investing billions of dollars in research, trials and manufacturing, there is concern that richer nations could scoop up promising medicines against the new coronavirus, leaving developing countries empty-handed. Bill Gates, Billionaire philanthropist (wish h...

Remdesivir: Gilead Wants More Profits! Initiates Clinical Trial Of Inhaled Remdesivir For Less-Severe COVID-19 With Hopes That Trump Admin Will Support It Again

Source: Remdesivir Jul 12, 2020 5 years ago

Remdesivir: Pharma giant Gilead Sciences wasted no time beginning testing of an inhaled formulation of its COVID-19 drug remdesivir for mild and less severe COVID-19 patients with the hope that the US FDA and Trump administration will support its approval again and buy up overpriced stocks once again with tax payers monies. We are not sure what basis the inhaled version of the drug will be approve...

COVID-19 Controversies: Researchers From Establishment Famed For Fraud and Deceit Publishes Study Showing That Remdesivir Has ‘Efficacy’ Against SARS-CoV-2

Source: COVID-19 Controversies Jul 10, 2020 5 years ago

COVID-19 Controversies: Despite the fact that Pharmaceutical giant Gilead has huge resources and research facilities, it was never demonstrated that Remdesivir had any direct effects in terms of inhibiting the SARS-CoV-2 replication capability in vitro or vivo studies. The only things it had that made the Trump administration pass the FDA approval as a drug for COVID-19 was 'half-baked' st...

WARNING! COVID-19 Drugs: Study Shows Elderly COVID Patients Have Increased Risks Of Bradycardia When Given Lopinavir and Ritonavir

Source: COVID-19 Drugs Jul 10, 2020 5 years ago

COVID-19 Drugs: Despite numerous studies showing that Lopinavir and Ritonavir are not effective to treat COVID-19, we still have numerous ignorant countries and doctors still using those drugs in their treatment protocols. Now a new French study shows that older, critically ill patients with COVID-19 who received a combination of the antiretroviral medications lopinavir and ritonavir experienced ...

COVID-19 Drugs: New Sedative Drug BXCL510 Specially Created To Calm COVID-19 Patients Following Intubation Or Having Delirium In ICU Settings

Source: COVID-19 Drugs Jul 09, 2020 5 years ago

COVID-19 Drugs: There is now an increased demand for a variety of drugs to treat the growing variety of symptoms and conditions associated with COVID-19. One of which is the assortment of different types of neurological conditions. Just for one neurological category of symptoms which is delirium, BioXcel Therapeutics, which is based in Connecticut has developed a new drug called BXCL510. ...

COVID-19 Drugs: Coronavir, A New Antiviral To Treat COVID-19 Approved For Use By Regulatory Agency in Russia

Source: COVID-19 Drugs Jul 09, 2020 5 years ago

COVID-19 Drugs: R-Pharm, a Russian pharmaceutical company has secured regulatory approval for the use of its antiviral drug Coronavir, to treat patients suffering from Covid-19. The company released the announcement today to Russian media. The regulatory approval comes after a clinical trial in mild to moderate Covid-19 patients showed that the drug is highly effective in blocking replica...

COVID-19 Drugs: Queensland University of Technology and Oxford University Exploring Budesonide Inhaler Therapy For Early COVID-19 Patients In New Trial

Source: COVID-19 Drugs Jul 08, 2020 5 years ago

COVID-19 Drugs: Medical researchers from Queensland University of Technology and Oxford University are working in collaboration to begin human clinical trials of inhaled corticosteroids, commonly used for asthma patients, on patients with COVID-19. The researchers believe that this could be useful for patients with the novel coronavirus infection. Research has shown that some corticosteroids,&nbs...

COVID-19 Drugs: University Of South Florida And University Of Arizona Researchers Identify Drug Candidates That Target The Viral Protease MPro

Source: COVID-19 Drugs Jul 07, 2020 5 years ago

COVID-19 Drugs: Researchers from University of South Florida Health (USF Health) Morsani College of Medicine scientists along with pharmaceutical experts from the University of Arizona College of Pharmacy have identified several existing drug compounds that block replication of the COVID-19 virus (SARS-CoV-2) within human cells grown in the laboratory. The identified inhibitors all demon...

Generic Remdesivir: While Americans Have To Pay Up To US$3120 For Gilead’s Remdesivir, Price War In India Has Led Prices Dropping To Below US$50!

Source: Generic Remdesivir Jul 06, 2020 5 years ago

Generic Remdesivir: The Trump administration last week proudly announced that it had secured 500,000 doses of Gilead’s remdesivir at prices that were set by Gilead at between US$2,340 to US$3,120. https://www.thailandmedical.news/news/breaking-remdesivir-gilead-sets-price-at-us$2,340-to-us$3,120-for-drug-that-has-no-safety-studies-or-true-efficacy-except-that-it-shortens-hospitaliza ...

COVID-19 Pharma News: Merck Initiates Clinical Trial Of TLR7 And TLR8 Inhibitor To Treat Severe COVID-19

Source: Jul 05, 2020 5 years ago

COVID-19 Pharma News: Pharma giant Merck, a leading science and technology company, announced that the US FDA has cleared its investigational new drug application (IND) for M5049 for the treatment of patients with Covid-19 pneumonia. Merck will initiate a Phase II randomized, controlled clinical study evaluating the safety and efficacy of M5049 in this patient population. M5049 is a potentially fi...

Melatonin and COVID-19: More Studies Emerging That Melatonin Is Useful As An Adjuvant Treatment For COVID-19 Due to Its Anti-Inflammatory Properties.

Source: Melatonin and COVID-19 Jul 05, 2020 5 years ago

Melatonin and COVID-19: Another study by researchers from Peking Union Medical College in China and the University of Texas- San Antonio in America have in a new peer-reviewed finding that is published in the journal: Life Sciences By Science Direct, propose that Melatonin should be incorporated as an adjuvant treatment for COVID-19 as it has proven mechanisms to target Inflammasomes that triggers...

Warning! COVID-19 Clinical Care: Alert About Drug Interactions When Treating COVID-19 Patients With Anticancer Drugs While On Antivirals

Source: COVID-19 Clinical Care Jul 04, 2020 5 years ago

COVID-19 Clinical Care: Researchers are expressing that more safety data is needed in terms of treatment of symptomatic COVID-19 patients on antivirals with anticancer drugs. A report published in the European Journal of Cancer by a group of French investigators led by Dr Paul Gougis of the Department of pharmacology, Hôpital Pitié-Salpêtrière in Paris, Franc...

COVID-19 Drugs: U.S. FDA Approves Siltuximab To Treat Acute Respiratory Distress Syndrome (ARDS) In COVID-19 Patients

Source: COVID-19 Drugs Jul 04, 2020 5 years ago

COVID-19 Drugs: EUSA Pharma has secured approval from the U.S. Food & Drug Administration (FDA) for a Phase III clinical trial protocol of intravenous siltuximab plus standard of care in hospitalized patients with Covid-19 associated Acute Respiratory Distress Syndrome (ARDS). The pharmaceutical company will now proceed with the randomized, double-blind, placebo-controlled clinical trial to e...

COVID-19 Drugs: Researchers Advocate Using Erythropoietin (EPO) As An Adjuvant Treatment For COVID-19

Source: COVID-19 Drugs Jul 03, 2020 5 years ago

COVID-19 Drugs and Erythropoietin: German researchers from the Max Planck Institute of Experimental Medicine in Göttingen suggest that the anemia drug Erythropoietin (Epo) which is sometimes misused as doping agent could also be effective against COVID-19. EPO, the growth factor could also mitigate severe disease progression and protect patients from long-term neurological effects when the ...

BREAKTHROUGH! COVID-19 Drugs: Data And Text Mining Platform Yields 32 Drug Candidates And 73 Prospective Drug Combinations To Fight SARS-COV-2

Source: COVID-19 Drugs Jul 03, 2020 5 years ago

COVID-19 Drugs: Researchers from the University of North Carolina (UNC) have used a new web-based platform to help identify synergistic and antagonistic drug combinations and their underlying mechanisms of action in the context of fighting the SARS-CoV-2 coronavirus disease. The data mining tool, called COVID-KOP, prioritized 73 combinations of 32 drugs as potential treatments for COVID-1...

COVID-19 Drugs: Fostamatinib Being Advocated To Be Repurposed To Treat Acute Lung Injury In COVID-19 By Harvard And Imperial College Researchers

Source: COVID-19 Drugs and Fostamatinib Jul 02, 2020 5 years ago

COVID-19 Drugs: Fostamatinib, an FDA-approved monoclonal antibody that is a spleen tyrosine kinase inhibitor (SYK), was studied by researchers from Harvards’ Broad Institute, Imperial College’s Hammersmith Hospital, Brigham and Women’s Hospital and Harvard Medical School for possible use to reduce the levels of mucin-1, a molecule associated with acute lung injury and acute respi...

COVID-19 Clinical Trials: Ireland Starts Study To Investigate Alpha-1-Antitrypsin for Severe Infections

Source: COVID-19 Clinical Trials Jul 01, 2020 5 years ago

COVID-19 Clinical Trials: Researchers from RCSI University of Medicine and Health Sciences-Ireland have begun a clinical trial of a promising therapy for critically ill COVID-19 patients in intensive care. A study published in the American Journal of Respiratory and Critical Care Medicine by the team led by RCSI Professors Dr Gerry McElvaney and Dr Ger Curley, describe changes in the...

COVID-19 Drugs: Cidofovir, Abacavir, Valganciclovir, Stavudine, And Entecavir Identified As Being Able To Shut Down SARS-Cov-2 Polymerase Reaction

Source: COVID-19 Drugs Jul 01, 2020 5 years ago

COVID-19 Drugs: The SARS-CoV-2 coronavirus typically uses a protein called polymerase to replicate its genome inside infected human cells. Studies have shown that terminating the polymerase reaction will stop the growth of the coronavirus, leading to its eradication by the human host's immune system. Now researchers from Columbia University and the University of Wisconsin-Madison have...

COVID-19 Drugs: RECOVERY Trial Study Confirms Lopinavir-Ritonavir Has No Clinical Benefits In Hospitalized COVID-19 Patients

Source: COVID-19 Drugs Jun 30, 2020 5 years ago

COVID-19 Drugs: More emerging results from the ongoing international RECOVERY Trail project shows that Lopinavir-Ritonavir has no clinical benefits in hospitalized COVID-19 treatments. Readers should also take note that in February 2020, Thai ‘medical experts’ held a huge press conference to announce that they had invented a treatment protocol to treat COVID-19 using Lopinavir-Ritonavi...

BREAKING! Remdesivir: Gilead Sets Price At US$2,340 to US$3,120 For Drug That Has No Safety Studies or True Efficacy Except That It Shortens Hospitalization Stays.

Source: Remdesivir and COVID-19 Jun 30, 2020 5 years ago

Remdesivir: No one is sure yet as to how much certain family members of Trump or the relatives of the US FDA could be making, but its interesting to see that the US FDA under the Trump administration had approved a drug to treat COVID-19 despite the fact there are no true detailed safety studies on the drug and also the fact there is no real efficacy demonstrated except that it shortens hospitaliz...

EXCLUSIVE! COVID-19 Drugs & Vaccines: A List Of All The Research And Developments Underway Encompassing More Than 149 Projects.

Source: COVID-19 Drugs & Vaccines Jun 29, 2020 5 years ago

COVID-19 Drugs And Vaccines: As the total number of global confirmed COVID-19 Infections reaches 10,267, 578 and the total confirmed deaths due to the SARS-CoV-2 coronavirus reaches 504, 812 (29th June, 2.45am California), people everywhere and healthcare professionals are getting more anxious as to date there are no real confirmed drugs or treatments protocols that can really treat COVID-19 effec...

BREAKING! COVID-19 Treatments: Amino-Acids Cysteine and Theanine Could Have Efficacy Against SARS-CoV-2 According To Japanese Study

Source: COVID-19 Treatments Jun 28, 2020 5 years ago

COVID-19 Treatments: The oral administration of the amino-acids Cysteine and Theanine could attenuate SARS-CoV-2 viral infection, replication and associated symptoms of COVID-19 such as cytokine storm according to Japanese researchers from the Research Institute for Bioscience Products & Fine Chemicals, Ajinomoto Co., Inc. The preprint study that is yet to be peer-reviewed is publishe...

Occulus Hirsutus and AQCH: India Discreetly Developing And Testing COVID-19 Drug Based On Phytochemicals Extracted From Occulus Hirsutus Plant

Source: Occulus Hirsutus and AQCH Jun 27, 2020 5 years ago

Occulus Hirsutus and AQCH: For the past 4 months India has been secretly working with teams of medical, biotech, biomolecular and pharmaceutical experts in developing an antiviral drug to treat COVID-19 using extracted phytochemicals from the Occulus Hirsutus plant. The plant Cocculus hirsutus (Linn.) Diels (Menispermaceae), described in traditional indian medicine ayurvedic literatu...

BREAKING! Colchicine, An Ancient Pharmaceutical Shows Positive Results In Early Clinical Trial To Treat Severe COVID-19

Source: Colchicine And COVID-19 Jun 25, 2020 5 years ago

Colchicine and COVID-19: Greek researchers have reported success in a small early clinical trial using an ancient drug called Colchicine to treat patients with severe COVID-19. The clinical trial results were published yesterday in the journal: JAMA Network Open. https://jamanetwork.com/searchresults?q=Spyridon%20Deftereos&f_SiteID=214&SearchSourceType=3&exPrm_qqq={!payloadDisMaxQPars...

Favipiravir: Studies Involving Animal Models Shows Favipiravir Has Very Weak Effect On SARS-CoV-2 And Not Viable As An Effective Therapeutic

Source: Favipiravir And COVID-19 Jun 23, 2020 5 years ago

Favipiravir: The COVID-19 pandemic has made the medical and pharmaceutical world one big circus with many charlatans including Government authorities for the sake of greed, power or ego endorsing drugs that do not have any proven efficacy to treat the COVID-19 disease let alone safety studies done on their usage. One example is hydroxychloroquine and we are not going to elaborate on it here as eve...

COVID-19-Drugs: German Researchers Show That Cancer Drug Ruxolitinib Can Help Treat COVID-19 Patients With Acute Respiratory Distress

Source: COVID-19-Drugs Jun 23, 2020 5 years ago

COVID-19-Drugs: German researchers from Marburg University Hospital claim that the cancer drug ruxolitinib is able to stop inflammatory processes in COVID-19 patients with acute respiratory syndrome (ARDS). Their research findings were published in the journal: Nature https://www.nature.com/articles/s41375-020-0907-9 Dr Thomas Wiesmann who is from intensive care team in the D...

MUST READ! COVID-19 Natural Cures: University Of Alabama Identifies 125 Naturally Occurring Plant Phytochemicals That Could Inhibit COVID-19

Source: COVID-19 Natural Cures Jun 22, 2020 5 years ago

COVID-19 Natural Cures: Researchers from the University of Alabama in Huntsville (UAH) has identified 125 naturally occurring compounds that have a computational potential for efficacy against the COVID-19 virus from the first batch of 50,000 compounds rapidly assessed by a supercomputer. A supercomputer is being utilized to assess the treatment efficacy of naturally occurring compounds a...

Ivermectin and COVID-19: Study Published In Nature Journal Suggest That Ivermectin Could Be A Complementary Antiviral Drug To Help Treat COVID-19

Source: Ivermectin And COVID-19 Jun 21, 2020 5 years ago

Ivermectin and COVID-19: Despite initial molecular docking studies and vitro studies showing a potential of using Ivermectin to treat COVID-19, there has only been a few clinical trials and even then despite having positive results, not much is talked about Ivermectin as its basically a drug whose patent has lapsed and hence it is not profitable for many pharmaceutical giants to promote it. To als...

Researchers Warn That Azithromycin Should Not Be Used For COVID-19

Source: Azithromycin and COVID-19 Jun 21, 2020 5 years ago

Azithromycin: In a new study published in the Oxford Journal: Open Forum Infectious Disease, researchers Dr Jeniffer Lighter and Dr Vanessa Raabe from New York University School of Medicine warn against the use of the antibiotic azithromycin to treat COVID-19. https://academic.oup.com/ofid/article/7/6/ofaa207/5849083 In the mad scramble to find drugs to treat COVId-19 and the testing of v...

BREAKING! Cannabis And COVID-19: Caflanone, A Flavonoid Extracted From A Distinct Cannabis Strain Could be A Therapeutic Drug Against the COVID-19

Source: Cannabis And COVID-19 Jun 20, 2020 5 years ago

Cannabis And COVID-19: According to researchers from Harvard Medical School, Northeastern University, Concordia University of Wisconsin and Vilotos Pharmaceuticals Inc, Caflanone (FBL-03G) a flavonoid extracted from a rare strain of cannabis found in Jamaica called Black Swan could hold therapeutic properties to treat COVID-19. The research findings were published in the journal : Molecul...

BREAKING! Tocilizumab (Actemra): Roche’s Rheumatoid Arthritis Drug Fails To Treat COVID-19 Patients In Italian Study

Source: Tocilizumab or Actemra Jun 18, 2020 5 years ago

Tocilizumab: Pharma giant Roche’s rheumatoid arthritis drug, Actemra (Tocilizumab) failed to help COVID-19 patients in Italian study according to the clinical trial findings released today. The drug failed to help patients with early-stage COVID-19 pneumonia in an Italian study, the latest instance in another an anti-inflammatory drug has fallen through in a coronavirus ...

WHO Stops All Trials Involving Hydroxychloroquine on COVID-19 Patients

Source: WHO Jun 18, 2020 5 years ago

WHO: The World Health Organization finally decided Wednesday to halt all trials of hydroxychloroquine as a potential treatment for hospitalized COVID-19 patients, finding it did not reduce the mortality rate. The malaria and rheumatoid arthritis drug, hydroxychloroquine has been at the center of political and scientific controversy. It has been touted as a possible treatment for th...

Interesting Reads

SARS-CoV-2 XEC Variant Shows Enhanced Immune Evasion through NTD Glycosylation

Nikhil Prasad
Oct 24, 2024 2 months ago

Many exposed to COVID-19 will develop Acute Ischemic Colitis!

Nikhil Prasad
Oct 21, 2024 2 months ago

Breaking News! Study Reveals Potential New Form of Brain Neurodegeneration Linked to COVID-19!

Nikhil Prasad
Oct 02, 2024 3 months ago

Word-Finding Challenges Linked to Post-COVID-19 Syndrome

Nikhil Prasad
Oct 02, 2024 3 months ago

Italian study discovers new subtype of T-cells as immune players in COVID-19

Nikhil Prasad
Sep 29, 2024 3 months ago

Texas scientist warns of new SARS-CoV-2 neuroinvasion pathway involving the trigeminal nerve

Nikhil Prasad
Sep 26, 2024 3 months ago

Researchers warn that SARS-CoV-2 can infect the Meibomian glands of the eyes

Nikhil Prasad
Jul 26, 2024 5 months ago

SARS-CoV-2 spike protein accelerates aging of blood vessels

Nikhil Prasad
Jul 23, 2024 5 months ago

Forget about the KP.3, LB.1, KP.2.3 variants. The new SARS-CoV-2 KP.3.1.1 is leading the current global COVID-19 surge

Nikhil Prasad
Jul 21, 2024 5 months ago

SARS-CoV-2 Causes ACE2 Downregulation and Unique Fibrosis That Contribute to Long COVID-19

Nikhil Prasad
Jun 28, 2024 6 months ago

COVID-19 and Stroke: New Insights on Inflammation and Recovery

Nikhil Prasad
Jun 22, 2024 6 months ago

Herbs And Phytochemicals: Oleuropein From Olive Leaf Can Help Against Colorectal Cancer

Nikhil Prasad
Jun 15, 2024 6 months ago

COVID-19 News: Researchers Warn That SARS-CoV-2 Infections Can Lead To Splenic Infarctions!

Nikhil Prasad
Dec 14, 2023 1 year ago

BREAKING COVID-19 News! SARS-CoV-2 Affects Red Blood Cell Morphology!

Nikhil Prasad
Oct 04, 2023 1 year ago

Study Shockingly Shows That Many Exposed To The SARS-CoV-2 Omicron Variant Exhibit Hematuria And Proteinuria! Early Signs Of Possible Kidney Damage?

COVID-19-News-Omicron-Hematuria-Proteinuria-Kidney-Damage
May 30, 2023 2 years ago

Phenolic Phytochemicals From The Roselle Plant Or Hibiscus Sabdariffa (Thai: Krachiap กระเจี๊ยบ) Can Treat And Prevent Obesity

Herbs And Phytochemicals - Roselle - Obesity
Mar 08, 2023 2 years ago

COVID-19 News: Will SARS-CoV-2 Infections Ultimately Lead To An Increased Incidence Of Head And Neck Cancers?

COVID-19 News - Head And Neck Cancers - By Nikhil P & Kittisak M
Feb 02, 2023 2 years ago

Study Validates Previous Findings That SARS-CoV-2 Reinfections Are Now Occurring At Shorter Intervals. Current CDC and ECDC Reinfection Definitions Are Obsolete!

Source: Medical News - SARS-CoV-2 Reinfections - Omicron
Sep 28, 2022 2 years ago

Quercetin Emerging As One Of The Must Take COVID-19 Supplements Especially When Considering The Omicron Variant And Long COVID-19 Issues

Source: COVID-19 Supplements - Quercetin
Jan 02, 2022 3 years ago

BREAKING! New International Study Warns That SARS-CoV-2 Infections Will Lead To Cancers Especially Colorectal Cancers Due to Disruption In Autophagy!

Source: SARS-CoV-2-Cancer
Nov 18, 2021 3 years ago

BREAKING! COVID-19 Genetics: Yale Scientist Identify Eight ‘Super’ Genetic Variants In White People That Increases COVID-19 Death Risk!

Source: COVID-19 Genetics
Nov 13, 2020 4 years ago

Japanese Study Shows That Ozone Water Rapidly Inactivates SARS-Cov-2 Coronavirus, Making It An Ideal COVID-19 Disinfectant And Sanitizer

Source: Ozone Water-COVID-19
Nov 05, 2020 4 years ago

BREAKING NEWS! COVID-19 Study Reveals That SARS-CoV-2 Uses CD4 Cells To Infect T-helper Lymphocytes. COVID-19 A Potent Version Of Airborne HIV?

Source: BREAKING NEWS
Sep 30, 2020 4 years ago

COVID-19 News: Emerging Studies Shows SARS-CoV-2 Attacks The Digestive Tract Especially The Intestines Directly, Reported Case Of Bowel Perforation

Source: COVID-19 News
Sep 21, 2020 4 years ago

BREAKING NEWS! Study Of COVID-19 Recovered Patients In China Reveals That Lymphocytes Are Drastically Altered To Become Dysfunctional With Immunity Implications

Source: COVID-19 Recovered Patients
Jul 02, 2020 5 years ago

Occulus Hirsutus and AQCH: India Discreetly Developing And Testing COVID-19 Drug Based On Phytochemicals Extracted From Occulus Hirsutus Plant

Source: Occulus Hirsutus and AQCH
Jun 27, 2020 5 years ago

High-Flow Nasal Cannula: For COVID-19 Second Wave Preparations, Forget About Ventilators, Doctors Are Now Turning To High-Flow Nasal Cannula

Source: High-Flow Nasal Cannula
Jun 25, 2020 5 years ago

BREAKING! Androgens: Study Shows Bald Men Mostly Likely To Suffer Severe COVID-19 Conditions Due To High Levels Of Androgens

Source: Androgens And COVID-19
Jun 23, 2020 5 years ago

BREAKING NEWS! COVID-19 Research Shows That SARS-CoV-2 Coronavirus Can Survive In Water For Up To 25 Days And Could Also Be Water-Borne

Source: COVID-19 Research
Jun 23, 2020 5 years ago

BREAKING! Hepatitis B: UAE COVID-19 Case Study Indicates That COVID-19 Could Induce Hepatitis B Virus Reactivation

Source: Hepatitis B and COVID-19
Jun 21, 2020 5 years ago

BREAKING! COVID-19 Research: Sodium Channels Could Be Affected As Coronavirus Spike Protein Has Similar Sequence To Human Epithelial Sodium Channel

Source: COVID-19 Research
Jun 21, 2020 5 years ago

BREAKING! Cannabis And COVID-19: Caflanone, A Flavonoid Extracted From A Distinct Cannabis Strain Could be A Therapeutic Drug Against the COVID-19

Source: Cannabis And COVID-19
Jun 20, 2020 5 years ago

Gargling: New Studies Show That Throat Gargling May Be Beneficial After All During COVID-19 Despite Being Labeled In the Past As Misinformation

Source: Gargling and COVID-19
Jun 19, 2020 5 years ago

BREAKING! COVID-19 Research: New Study Reveals That SARS-CoV-2 Coronavirus Also Affects Thyroid Functions In Majority Of COVID-19 Patients

Source: COVID-19 Research
Jun 17, 2020 5 years ago

Exploring Inhaled Nitric Oxide (iNo) As As An Adjuvant COVID-19 Treatment For Pulmonary Issues

Source: Nitric Oxide and COVID-19
Jun 15, 2020 5 years ago

Understanding The Differences Between COVID-19 Asymptomatic and Presymptomatic Conditions

Source: COVID-19 Asymptomatic and Presymptomatic
Jun 14, 2020 5 years ago

Scripp Institute Has Detected The Mutation That Most Scientist Dread: The D614G Mutation Which Could Make The SARS-CoV-2 More Infectious

Source: SARS-CoV-2 Mutations
Jun 13, 2020 5 years ago

BREAKING! Medical Experts Warn That COVID-19 Could Trigger Diabetes In Otherwise Healthy Individuals Who Never Had The Condition Before.

Source: Diabetes and COVID-19
Jun 13, 2020 5 years ago

Acute Pancreatitis: Warning That Acute Pancreatitis Is Now Manifesting In COVID-19 Patients, A Condition Never Seen In Early Stages Of The Pandemic

Source: Acute Pancreatitis
Jun 11, 2020 5 years ago

Immune Health: Cistanche And Pu-erh Tea Supplements Could Help Improve Immune Factors And Reduce Pro-inflammatory Cytokines Such As Interleukin-6

Source: Immune Health
Jun 09, 2020 5 years ago

Study Finds That COVID-19 Also Causes Myocardial Injury (Heart Damage)

Source: Myocardial Injury
Jun 09, 2020 5 years ago

European COVID-19 Research Indicates That Individuals With Blood Group Type A Might Be More Vulnerable To Respiratory Failure

Source: COVID-19 Research
Jun 08, 2020 5 years ago

Supplements: Singaporean Researchers Say That Vitamin D, Magnesium And Vitamin B12 Combo May Reduce Severity In Older COVID-19 Patients

Source: Supplements And COVID-19
Jun 06, 2020 5 years ago

MUST READ! Strokes: Study Shows COVID-19 Increases Risk Of Strokes In Healthy Young Individuals. Global Increase In Stroke Deaths Last Few Months

Source: Strokes And COVID-19
Jun 05, 2020 5 years ago

BREAKING ALERT! COVID-19: Italian Researchers Discover Brain Lesions On COVID-19 Patients

Source: COVID-19
May 23, 2020 5 years ago

FROM ZIKA VIRUS

LATEST ON STDS

World COVID-19 News

COVID-19 Diagnostics

COVID-19 Drugs

COVID-19 Supplements

COVID-19 Herbs

COVID-19 Disinfectants

COVID-19 Mutations

COVID-19 Research

COVID News

Long COVID

COVID-19 Vaccines

COVID-19 Clinical Care

Medical Press Releases

Medical Innovations & Startups

AI in Medicine

Thailand Biotech News

Medical Spheres Bulletins

Medical White Papers

Medical Packages

Medical Tips

Medical Support Groups

MOST READ

Interesting Reads

FROM ZIKA VIRUS

LATEST ON STDS